Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: Several studies have documented that a variety of pharmacological compounds are quite effective in controlling acute symptomatology of panic disorder in the general population. However, there is a paucity of such studies in the management of panic disorder in older adults (ages 55 and above). The purpose of this study was to gather pilot data in older patients with panic disorder to begin to assess the efficacy of two commonly-used antipanic medications, imipramine and alprazolam. Method: Twenty-five ( n = 25 (23 females; 2 males); 18 completers, 7 dropouts) older panic disorder (DSM-III-R) patients (age range = 55–73; mean = 61.24) were studied in an eight-week randomized, parallel-groups, double-blind, placebo-controlled, flexible dose design. Outcome was assessed weekly by global change ratings (Hamilton Anxiety and Depression Scales; Physicians' Global Impression ratings) and panic diaries. Because of small sample size, we present data descriptively. Results: Subjects in active medication groups evidenced reductions in panic attacks and in levels of overall anxiety and depression. Therapeutic dosages were approximately half those commonly used in younger panic disorder patients. Conclusion: Our data suggest the comparable efficacy of alprazolam and imipramine in the short-term treatment of older adults with panic disorder. There is clearly the need for a larger scale placebo-controlled study, preferably comparing imipramine and/or alprazolam with one of the SSRIs, to substantiate our findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90072-9 · Cited by 1,044 · cited 1×
“The HAM-A has become an established measure for anxiety severity, change, and outcome in clinical trials [25].”
MethodBallenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Lactate Provocation of Panic Attacks: I. Clinical and Behavioral Findings
Liebowitz, M. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190038004 · Cited by 397 · cited 1×
“Of the various anxiety disorders, panic disorder has been the best studied over the last decade or so, probably because of its distinct qualitative difference from everyday anxiety and relatively clear characterization compared to other anxiety disorders [3-5].”
BackgroundParoxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.683 · Cited by 144 · cited 1×
“More recently, several researchers have demonstrated efficacy of the selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, paroxetine, and fluvoxamine in panic disorder [12, 13, 19, 20].”
Background
Cited by
Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
Dubovsky, S. L., & Marshall, D. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524400 · Cited by 171
Offidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
The acute effects of L‐theanine in comparison with alprazolam on anticipatory anxiety in humans
Lu, K., Gray, M. A., Oliver, C., Liley, D. T., Harrison, B. J., Bartholomeusz, C. F., Phan, K. L., & Nathan, P. J. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.611 · Cited by 139
“This is supported by the clinical studies that demonstrate anxiolytic effects of alprazolam in anxiety disorders (including generalized anxiety disorder and panic disorder) only following chronic administration (Laakmann et al., 1998; Lydiard et al., 1997; Sheikh and Swales, 1999).”
ResultPinquart, M., & Duberstein, P. R. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31806841c8 · Cited by 126
Evidence-based treatment of geriatric anxiety disorders
Wetherell, J. L., Lenze, E. J., & Stanley, M. A. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.09.006 · Cited by 94
Metadata
- Authors
- Sheikh, J. I., & Swales, P. J.
- Venue
- The International Journal of Psychiatry in Medicine
- Publisher
- SAGE Publications
- Published
- 1999-03
- Volume
- 29
- Issue
- 1
- Pages
- 107-117
- ISSN
- 0033-278X (ISSN-L)
- 0091-2174
- 1541-3527
- OpenAlex
- W2099328368
- Cited by
- 35
- References
- 5
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo. https://app.cochat.ai/papers/10.2190/kqej-mqjr-vk3d-f3hv
- The paper
- Sheikh, J. I., & Swales, P. J. (1999). Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/kqej-mqjr-vk3d-f3hv
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.